Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

antisense oligonucleotide therapy

(AN-tee-sents AH-lih-goh-NOO-klee-oh-tide THAYR-uh-pee)
Treatment with antisense oligonucleotides. These are small pieces of DNA or RNA that can bind to specific molecules of RNA. This blocks the cell’s ability to use the RNA to make a protein or work in other ways. Antisense oligonucleotides are being studied in the treatment of many types of cancer. Also called antisense therapy.
Search NCI's Dictionary of Cancer Terms